Guidewire Manipulation Based on Establishment of Stereo Perception in Percutaneous Coronary Intervention

基于立体感知建立的导丝操控在经皮冠状动脉介入治疗中的应用

阅读:2

Abstract

BACKGROUND: Traditional percutaneous coronary intervention (PCI) relies on two-dimensional X-ray imaging, but this does not allow depth perception and complicates precise manipulation of the guidewire. Our purpose was to develop a novel method for guidewire manipulation by establishing stereoscopic perception in coronary angiography (CAG), as described in our previous study, and thereby improve the precision and success rate of PCI. METHODS: Based on establishment of stereo perception in CAG, we used digital subtraction angiography (DSA) with gantry rotation and simulation with UG NX software to determine the orientation of the guidewire tip and the relative positions of the true lumen and false lumen. We then performed verification using a highly realistic 3D-printed transparent silicone model of the human heart and coronary arteries. By manipulating the guidewire in various branches of the model of the coronary artery, we identified the directional torque of wire rotation and simulated this using UG NX software. A preliminary trial with unidirectional rotation was conducted in which one interventionist performed 60 guidewire manipulations (30 before and 30 after training) in a 3D-printed heart model to quantify changes in directional accuracy. RESULTS: The results confirmed that the orientation of the distal tip of the guidewire and the relative positions of the true and false lumens were accurately determined using DSA with gantry rotation and simulation with UG NX software. We also validated the consistency of rotational torque within the coronary artery lumen, irrespective of vessel twisting and deformation. The preliminary trial demonstrated a higher success rate (93.3% vs. 60%, p < 0.01) after training. CONCLUSION: Our novel method significantly improved the accuracy of guidewire manipulation in an in vitro model. This method therefore has the potential to enhance PCI outcome, and warrants further examination by clinical trials.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。